Natixis Viatris Inc Transaction History
Natixis
- $16 Billion
- Q4 2024
A detailed history of Natixis transactions in Viatris Inc stock. As of the latest transaction made, Natixis holds 576,325 shares of VTRS stock, worth $5.49 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
576,325
Previous 78,725
632.07%
Holding current value
$5.49 Million
Previous $913,000
685.87%
% of portfolio
0.04%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding VTRS
# of Institutions
1,136Shares Held
986MCall Options Held
2.34MPut Options Held
2.21M-
Vanguard Group Inc Valley Forge, PA142MShares$1.35 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$883 Million0.02% of portfolio
-
State Street Corp Boston, MA63.7MShares$608 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$596 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD58.7MShares$559 Million0.08% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $11.6B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...